Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
2.675
-0.035 (-1.29%)
At close: Dec 9, 2025, 4:00 PM EST
2.720
+0.045 (1.68%)
After-hours: Dec 9, 2025, 4:47 PM EST
Nuwellis Market Cap
Nuwellis has a market cap or net worth of $4.44 million as of December 9, 2025. Its market cap has decreased by -6.91% in one year.
Market Cap
4.44M
Enterprise Value
1.78M
1-Year Change
-6.91%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since December 6, 2019, Nuwellis's market cap has increased from $3.25M to $4.44M, an increase of 36.74%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 4.50M | 10.45% |
| Dec 31, 2024 | 4.07M | 114.71% |
| Dec 29, 2023 | 1.90M | -65.92% |
| Dec 30, 2022 | 5.56M | -53.25% |
| Dec 31, 2021 | 11.90M | -35.49% |
| Dec 31, 2020 | 18.44M | 385.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |